AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22124712
Drug: No melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No melatonin administration prior to EEG recording
Trial: 16198658
Drug: Cyclosporine 100
RxNorm normalized name: cyclosporine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine 100 mg
Trial: 10439743
Drug: Neostigmine (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (0.07 mg/kg) with glycopyrrolate (0.01 mg/kg) given 5 min after relaxant
Trial: 38439
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (amounts: 150, 180, 210, 240 ml) ingested with each meal during a 12-day period.
Trial: 25886499
Drug: Patient education
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient education + 12-week supervised exercise therapy program
Trial: 19594771
Drug: Control (non-statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (non-statin treatment)
Trial: 15697105
Drug: 35 microg
RxNorm normalized name: Ethinyl estradiol 35 microgram and norethindrone 1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 microg Ethinylestradiol/2 mg Cyproterone Acetate (Diane 35, Schering) for 3 months
Trial: 15697105
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Medroxyprogesterone Acetate (MPA) x 10 days every month for 3 months (control group)
Trial: 12172440
Drug: Fixed-dose low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fixed-dose low molecular weight heparin (LMWH) Certoparin, 2 x 8000 aXa IU
Trial: 9596473
Drug: Cholera vaccine
RxNorm normalized name: Cholera Vaccine
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholera vaccine 1
Trial: 9596473
Drug: Cholera vaccine
RxNorm normalized name: Cholera Vaccine
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholera vaccine 2
Trial: 2539763
Drug: Quinapril (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (10, 20, and 40 mg/day)
Trial: 2539763
Drug: Enalapril (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10, 20, and 40 mg/day)
Trial: 81154
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg daily
Trial: 31058457
Drug: Self-monitoring urinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-monitoring urinary salt excretion measurement device for 4 weeks
Trial: 23218853
Drug: Nitroprusside gel
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nitroprusside gel (10 mg, 1 mL)
Trial: 23218853
Drug: Nitroprusside gel
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nitroprusside gel
Trial: 15308353
Drug: Men D
RxNorm normalized name: Glove Ladies/Men Dermal Large
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Men D (2 doses at 3 and 9 months)
Trial: 15308353
Drug: Men D
RxNorm normalized name: Glove Ladies/Men Dermal Large
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Men D (single dose in infancy)
Trial: 10958046
Drug: Gabapentin 1200
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 1200 mg/day (400 mg/day from 1st to 3rd day, 800 mg/day from 4th to 6th day, 1200 mg/day from 7th day)
Trial: 8623963
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg IV ephedrine
Trial: 8623963
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg IV ephedrine
Trial: 1836780
Drug: Placebo (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (same emulsion without active drug)
Trial: 6122755
Drug: Intestinal lavage
RxNorm normalized name: pork intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intestinal lavage with 18 L of normal saline administered via a jejunal tube over a period of 2 hours
Trial: 6122755
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving similar treatment without lavage
Trial: 26720458
Drug: Lutein (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein (10 mg) and antioxidant supplement
Trial: 26720458
Drug: Lutein and
RxNorm normalized name: ICaps Lutein and Omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein and antioxidant supplement in combination with PUFA
Trial: 24617431
Drug: Methotrexate (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (7.5 mg weekly)
Trial: 24617431
Drug: Ciclosporin (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclosporin (2.5 mg kg(‐1) daily)
Trial: 20048271
Drug: Cultural competency
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cultural competency training and monthly race-stratified performance reports
Trial: 15701591
Drug: Calcipotriol/betamethasone dipropionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol/betamethasone dipropionate ointment (Daivobet/Dovobet), applied once daily for 4 weeks.
Trial: 10520159
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dental treatment plus amphotericin B
Trial: 7781398
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus concurrent radiation therapy
Trial: 31234840
Drug: Pharmacist-led intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-led intervention including identification of drug related problems, drug interactions, change in dose, frequency and therapy switches, and non-pharmacological intervention consisting of diet, lifestyle and behavior counseling
Trial: 29217757
Drug: Elamipretide (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elamipretide (0.25 mg·kg‐1·h‐1)
Trial: 23803594
Drug: Neostigmine 10
RxNorm normalized name: neostigmine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 10 µg kg(‐1)
Trial: 23803594
Drug: Neostigmine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 20 µg kg(‐1)
Trial: 23803594
Drug: Neostigmine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 30 µg kg(‐1)
Trial: 16330915
Drug: Clopidogrel in
RxNorm normalized name: Product containing clopidogrel in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel in combination with aspirin
Trial: 16330915
Drug: Combination antiplatelet
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination antiplatelet therapy with clopidogrel and aspirin
Trial: 7806018
Drug: Subjects with
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subjects with non-insulin-dependent diabetes mellitus
Trial: 3286064
Drug: Fasting insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fasting insulin concentration
Trial: 7806018
Drug: 30-min insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-min insulin increment
Trial: 51576
Drug: Menaquinone therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menaquinone therapy alone
Trial: 51576
Drug: Menaquinone therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menaquinone therapy with hyposensitization therapy
Trial: 30111240
Drug: Tenease therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenease therapy (mechanical high-frequency vibration device)
Trial: 30111240
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (physiotherapy, activity modification, and analgesia)
Trial: 19861956
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy (SMT) for 12 weeks
Trial: 17593012
Drug: Topical pranoprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical pranoprofen 0.1%
Trial: 11972097
Drug: Total transfusion
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total transfusion volume of more than 250 mL/kg
Trial: 9504437
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline orally at 0100 h
Trial: 9504437
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline orally at 0700 h
Trial: 9504437
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline orally at 1300 h
Trial: 9504437
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline orally at 1900 h
Trial: 8699518
Drug: Threaded, hydroxylapatite-coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Threaded, hydroxylapatite-coated implant
Trial: 132695
Drug: Feprazone, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feprazone, 200 mg t.d.s.
Trial: 132695
Drug: Indomethacin, 25
RxNorm normalized name: Indomethacin, 25 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin, 25 mg t.d.s. rising to 50 mg t.d.s.
Trial: 29187388
Drug: Almond diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almond diet (ALD) - 42.5 g/d of almonds
Trial: 29187388
Drug: Chocolate diet
RxNorm normalized name: chocolate allergenic extract
DrugBank: Cocoa (DB10977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chocolate diet (CHOC) - 18 g/d of cocoa powder and 43 g/d of dark chocolate
Trial: 25194428
Drug: Chamomile tea
RxNorm normalized name: Chamomile Tea
DrugBank: Chamomile (DB14357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile tea (3 g/150 mL hot water) three times per day immediately after meals for 8 weeks
Trial: 21984399
Drug: Astaxanthin (AST)
DrugBank: Astaxanthin (DB06543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astaxanthin (AST) 4 mg/d for 28 days
Trial: 1636574
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (1.5 million units/60 minutes)
Trial: 1636574
Drug: Intravenous anistreplase
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anistreplase (30 units/2 to 5 minutes)
Trial: 1636574
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase or anistreplase
Trial: 31914443
Drug: Allergen immunotherapy
RxNorm normalized name: Allergen immunotherapy extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allergen immunotherapy (AIT) plus pharmacological treatment
Trial: 24595228
Drug: Sevoflurane treatment
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane treatment (both intramyocardial and systemic)
Trial: 19939196
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oral folic acid supplement
Trial: 10683816
Drug: DHA (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (1.5 g DHA per day for 9 weeks)
Trial: 10683816
Drug: Control (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (10 capsules of mixed plant oil per day for 9 weeks)
Trial: 6130079
Drug: Buspirone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (10 mg t.i.d.)
Trial: 6130079
Drug: Diazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (10 mg t.i.d.)
Trial: 17606475
Drug: Lorazepam (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (1.5 mg)
Trial: 26120988
Drug: Vasonit and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasonit and standard treatment
Trial: 20530296
Drug: Current levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current levels of augmentation index
Trial: 18411833
Drug: Asthma psychoeducation
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Asthma psychoeducation program with family therapy
Trial: 10714568
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy consisting of stavudine + lamivudine + nelfinavir + saquinavir for 26 weeks
Trial: 2836204
Drug: Controlled-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release metoprolol 100 mg
Trial: 2836204
Drug: Controlled-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release metoprolol 200 mg
Trial: 29117643
Drug: Coated activated
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coated activated charcoal haemoperfusion (CAC‐HP) plus standard care (oral activated charcoal)
Trial: 29117643
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (oral activated charcoal)
Trial: 24318788
Drug: Neuromuscular training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromuscular training (20‐min warm‐up program performed twice weekly for 10 weeks)
Trial: 15328673
Drug: Fexofenadine hydrochloride
RxNorm normalized name: Fexofenadine Hydrochloride
DrugBank: Fexofenadine (DB00950)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexofenadine hydrochloride (20, 60, 120, or 240 mg twice daily)
Trial: 22369270
Drug: Corticosteroids treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids treatment
Trial: 8401048
Drug: Terbinafine 1%
RxNorm normalized name: Terbinafine 1% Topical application Gel/Jelly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 1% cream applied twice daily for one week
Trial: 8401048
Drug: Clotrimazole 1%
RxNorm normalized name: CLOTRIMAZOLE 1% LOTION
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole 1% cream applied twice daily for four weeks
Trial: 3780287
Drug: Prophylactic salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prophylactic salbutamol (200 micrograms 4-times daily)
Trial: 3780287
Drug: Symptomatic placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic placebo inhaler (2 actuations 4-times daily)
Trial: 19875685
Drug: Doxycycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (200 mg oral for 7 days)
Trial: 11089515
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg rizatriptan
Trial: 9358715
Drug: Both programs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both programs with nicotine-replacement therapy
Trial: 2939542
Drug: Placebo (discography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (discography followed by injection of distilled water)
Trial: 31604088
Drug: Intramuscular triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular triamcinolone
Trial: 25974640
Drug: LY2963016 insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2963016 insulin glargine
Trial: 25974640
Drug: Lantus® insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lantus® insulin glargine
Trial: 19589522
Drug: Minimal stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal stimulation using recombinant human FSH (rhFSH) and GnRH antagonist
Trial: 19589522
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist multiple-dose protocol (MDP)
Trial: 16310924
Drug: BXL628 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BXL628 150 mcg daily
Trial: 2844338
Drug: Intravenous cytomegalovirus
RxNorm normalized name: cytomegalovirus immunoglobulin
DrugBank: Human cytomegalovirus immune globulin (DB13886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cytomegalovirus immune globulin
Trial: 2844338
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no intravenous cytomegalovirus immune globulin)
Trial: 29742109
Drug: Active placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active placebo (tolterodine 1 mg)
Trial: 25413975
Drug: Phototherapy (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phototherapy (combination of super-pulsed laser and light-emitting diodes)
Trial: 23428336
Drug: L-Acetylcarnitine (LAC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Acetylcarnitine (LAC) plus placebo
Trial: 23428336
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 mg/die plus placebo
Trial: 18438230
Drug: W+B (water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: W+B (water + 5 g x L(‐1) betaine)
Trial: 18438230
Drug: C+B (6%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C+B (6% carbohydrate-electrolyte fluid + 5 g x L(‐1) betaine)
Trial: 16937274
Drug: Once-weekly 17.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly 17.5 mg risedronate
Trial: 16937274
Drug: Once-daily 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily 2.5 mg risedronate
Trial: 11128859
Drug: 38 mg
RxNorm normalized name: alloin 38 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 38 mg x kg(‐1) x d(‐1) of HMB
Trial: 11128859
Drug: 76 mg
RxNorm normalized name: menthol 76 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 76 mg x kg(‐1) x d(‐1) of HMB
Trial: 11128859
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg x kg(‐1) x d(‐1) (Control)
Trial: 8077790
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (well hydrated with cristalloid saline solution)
Trial: 795379
Drug: Fluocinonide gel
RxNorm normalized name: Fluocinonide Gel
DrugBank: Fluocinonide (DB01047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinonide gel
Trial: 795379
Drug: Betamethasone benzoate
RxNorm normalized name: Betamethasone Benzoate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone benzoate gel
Trial: 29149146
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg with bupivacaine 0.25%
Trial: 25142189
Drug: Palifermin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palifermin (60 μg/kg IV for 3 days before and after chemotherapy)
Trial: 19614803
Drug: Candesartan (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (32 mg) + Aspirin (300 mg/d)
Trial: 9660521
Drug: Barnidipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barnidipine (10 mg) once daily
Trial: 9660521
Drug: Nitrendipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (10 mg) once daily
Trial: 2039655
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg Aminophylline
Trial: 22097175
Drug: Prednisone treatment
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone treatment after regression of proteinuria (Group B)
Trial: 16982486
Drug: Zinc sulphate
RxNorm normalized name: Zinc sulphate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulphate (15 mg of zinc) once daily for prophylaxis, increased to 30 mg at onset of cold
Trial: 10649149
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol plus norethindrone acetate (50 microg/d estradiol + 140/250/400 microg/d norethindrone acetate)
Trial: 1341607
Drug: Pulsatile insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsatile insulin delivery (1.0 mU/kg x min in 2 minute pulses every 13 minutes)
Trial: 1341607
Drug: Continuous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous insulin delivery (0.15 mU/kg x min)
Trial: 1341607
Drug: Continuous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous insulin delivery (0.20 mU/kg x min)
Trial: 6130244
Drug: More intensive
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More intensive management program (group A) using ultralente insulin as basal cover and soluble insulin at mealtimes, with more frequent clinic visits, closer dietary supervision, and home blood glucose monitoring
Trial: 1771386
Drug: Magaldrate (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magaldrate (800 mg every 4 h)
Trial: 29500454
Drug: sacubitril/valsartan (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sacubitril/valsartan (400 mg QD)
Trial: 29500454
Drug: amlodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amlodipine (10 mg QD)
Trial: 24777959
Drug: Topical menthol
RxNorm normalized name: menthol Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical menthol application